According to Chugai Pharmaceutical's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.89234. At the end of 2023 the company had a P/S ratio of 7.99.
Year | P/S ratio | Change |
---|---|---|
2023 | 7.99 | 85.06% |
2022 | 4.32 | -27.97% |
2021 | 6.00 | -49.24% |
2020 | 11.8 | 46.72% |
2019 | 8.05 | 33.86% |
2018 | 6.01 | 2.45% |
2017 | 5.87 | 69.52% |
2016 | 3.46 | -25.57% |
2015 | 4.65 | 46.4% |
2014 | 3.18 | 12.33% |
2013 | 2.83 | 29.49% |
2012 | 2.18 | 15.82% |
2011 | 1.89 | -16.66% |
2010 | 2.26 |